Evergreening and operational risk under price competition

“Evergreening” is a strategy wherein an innovative pharmaceutical firm introduces an upgrade of its current product when the patent on this product expires. The upgrade is introduced with a new patent and is designed to counter competition from generic manufacturers that seek to imitate the firm...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Naval research logistics 2016-02, Vol.63 (1), p.71-89
Hauptverfasser:	Bala, Ram, Kunnumkal, Sumit, Sohoni, Milind G.
Format:	Artikel
Sprache:	eng
Schlagworte:	capacity allocation Competition Demand evergreening Financing Investment Markets pharmaceutical industry Prices Risk Strategic planning Thresholds Uncertainty
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!